The author reflects on the trend of genome-scale sequencing in clinical practice. He references two studies that establish molecular diagnosis and measure the value of clinical exome sequencing which relay the risks, benefits, and limitations of the testing method. He also suggests that genetic diagnosis of diseases could impact the care of patients and their families.